InnomarLive 2018: Top Trends In Health Policy

January 15, 2018

 

 

Wednesday April 4th, 2018

Toronto Airport Marriott Hotel | 901 Dixon Road | Toronto, ON

There are many factors affecting health care policy in Canada that will influence and shape pharmaceuticals in the future. As governments and the healthcare industry look for maximizing value, cost-effectiveness and efficiencies in the system, this InnomarLive session will assess the impact these trends are having and the potential opportunities within the pharmaceutical market. We will discuss and examine key trends through the lens of key decision makers from the patient, payer, industry and government perspective.

Hear from our panelists of leading experts throughout the day and participate in the afternoon session which provides a unique opportunity to individually meet with panelists in an intimate 1:1 private session that can explore individual or address specific needs to your business.

REGISTER NOW >

 

Guest Speakers:

  • Durhane Wong-Rieger, (Chair) President and CEO, CORD
  • Alexandra Chambers, Director pCODR
  • Sang Mi Lee, Senior Pharmacist, pCPA
  • Olaf Koester, Principal, OHWK Business Management Advisory
  • Barbara Martinez, Director, Great West Life
  • Joel Montesanti, Director, Ontario Ministry of Health and Long Term Care
  • Tanya Potashnik, Director, PMPRB
  • Glenn Monteith, Executive Advisor to the President, Innovative Medicines Canada (IMC)

Morning sessions highlights:

  • PMPRB Changes
  • Trends in the Quebec Landscape
  • Implementation of OHIP+ and SADIE
  • Policy trends in the province of Quebec
  • Emergence of pay for performance and risk sharing
  • Many more topics to be announced

Afternoon Session*

Features Private Consultations with panelists from the morning session who will address your strategic questions (limited availability)

VIEW THE AGENDA >

 

YOU SHOULD ATTEND IF YOU WORK IN…

  • Market Access / Reimbursement
  • Marketing / Market Research
  • Stakeholder Relations / Government Affairs
  • Drug Plan Management - Public & Private Payers
  • New Product Launches / Drug Commercialization

 

PRICING

  • $750:  Morning plenary, excluding afternoon session (per attendee)
  • $3,000:  2 attendees (full day)
  • $6,000:  3-5 attendees  (full day)

REGISTER NOW >

 

For more information contact:  InnomarLive@innomar-strategies.com

 

Share: